Sale!

Methyl 3-Aminocrotonate

2,600.00

Applications

Applications. Methyl 3-amino crotonate is used in synthesizing calcium channel blocking medicines utilized for treating hypertension. It is also used in the synthesis of Amlodipine Base and Amlodipine Besylate.

Description

Methyl 3-aminocrotonate is an intermediate in the synthesis of pyridinedicarboxylic acid. It is a white powder with a melting point of 160-165°C and a boiling point of 263°C. Methyl 3-aminocrotonate is soluble in water, alcohols, ethers, chloroform, and benzene.

Preparation

CONSTITUTION: Methyl acetoacetate is reacted with ammonia (1.5-4.0 mol ammonia to 1 mol methyl acetoacetate is pref.) in the presence of water (0.05-3.0 mol water to 1 mol methyl acetoacetate is pref.) in a temp. range of 35-70°C to obtain methyl 3-aminocrotonate.

Chemical Properties

Methyl 3-aminocrotonate is a chemical compound with properties related to its use as a precursor in organic synthesis, notably in the formation of various pharmaceutical and chemical compounds.

Definition

Methyl 3-aminocrotonate is an organic compound characterized by its structure containing an amino group, a methyl ester, and a conjugated double bond system, often used as a building block in organic synthesis.

Description

Product Name Methyl 3-Aminocrotonate
CAS Number 14205-39-1
Molecular Weight 115.13
Chemical Formula C5H9NO2
Melting point 81-83 °C(lit.)
Boiling point 112°C 42mm
Density 1.1808 (rough estimate)
vapor pressure 2.79-2.853hPa at 25℃
refractive index 1.4538 (estimate)
Flash point 91 °C
storage temp Keep in dark place,Inert atmosphere,2-8°C
solubility 18g/l
form Crystalline Powder
pka 5.27±0.70(Predicted)
color White to slightly yellow
PH 8-9 (18g/l, H2O, 20℃)
Water Solubility insoluble
Sensitive Hygroscopic
Packaging Size As Per Requirement

Our Export Location as a Methyl 3-Aminocrotonate Manufacturer, Supplier, Exporter, Stockist from India.

Afghanistan

Albania

Algeria

Andorra

Angola

Antigua and Barbuda

Argentina

Armenia

Australia

Austria

Austrian Empire

Azerbaijan

Baden

Bahamas

Bahrain

Bangladesh

Barbados

Bavaria

Belarus

Belgium

Belize

Benin (Dahomey)

Bolivia

Liberia

Libya

Liechtenstein

Lithuania

Luxembourg

Madagascar

Malawi

Malaysia

Maldives

Mali

Malta

Marshall Islands

Mauritania

Mauritius

Mecklenburg-Schwerin

Mecklenburg-Strelitz

Mexico

Micronesia

Moldova

Monaco

Mongolia

Montenegro

Bosnia and Herzegovina

Botswana

Brazil

Brunei

Brunswick and Lüneburg

Bulgaria

Burkina Faso

Burma

Burundi

Cabo Verde

Cambodia

Cameroon

Canada

Cayman Islands

Central African Republic

Central American Federation

Chad

Chile

China

Colombia

Comoros

Congo Free State

Costa Rica

Morocco

Mozambique

Namibia

Nassau

Nauru

Nepal

Netherlands

New Zealand

Nicaragua

Niger

Nigeria

North German Confederation

North German Union

North Macedonia

Norway

Oldenburg

Oman

Orange Free State

Pakistan

Palau

Panama

Papal States

Cote d’Ivoire

Croatia

Cuba

Cyprus

Czechia

Czechoslovakia

Democratic Republic of the Congo

Denmark

Djibouti

Dominica

Dominican Republic

Duchy of Parma

East Germany

Ecuador

Egypt

El Salvador

Equatorial Guinea

Eritrea

Estonia

Eswatini

Ethiopia

Federal Government of Germany

Fiji

Papua New Guinea

Paraguay

Peru

Philippines

Piedmont-Sardinia

Poland

Portugal

Qatar

Republic of Genoa*

Republic of Korea (South Korea)

Republic of the Congo

Romania

Russia

Rwanda

Saint Kitts and Nevis

Saint Lucia

Saint Vincent and the Grenadines

Samoa

San Marino

Sao Tome and Principe

Saudi Arabia

Schaumburg-Lippe*

Finland

France

Gabon

Gambia

Georgia

Germany

Ghana

Grand Duchy of Tuscany

Greece

Grenada

Guatemala

Guinea

Guinea-Bissau

Guyana

Haiti

Hanover

Hanseatic Republics

Hawaii

Hesse

Holy See

Honduras

Hungary

Iceland

Senegal

Serbia

Seychelles

Sierra Leone

Singapore

Slovakia

Slovenia

Solomon Islands

Somalia

South Africa

South Sudan

Spain

Sri Lanka

Sudan

Suriname

Sweden

Switzerland

Syria

Tajikistan

Tanzania

Texas

Thailand

India

Indonesia

Iran

Iraq

Ireland

Israel

Italy

Jamaica

Japan

Jordan

Kazakhstan

Kenya

Kingdom of Serbia/Yugoslavia

Kiribati

Korea

Kosovo

Kuwait

Kyrgyzstan

Laos

Latvia

Lebanon

Lesotho

Lew Chew (Loochoo)

Timor-Leste

Togo

Tonga

Trinidad and Tobago

Tunisia

Turkey

Turkmenistan

Tuvalu

Two Sicilies*

Uganda

Ukraine

Union of Soviet Socialist Republics*

United Arab Emirates

United Kingdom

Uruguay

Uzbekistan

Vanuatu

Venezuela

Vietnam

Württemberg*

Yemen

Zambia

Zimbabwe

Reviews

There are no reviews yet.

Be the first to review “Methyl 3-Aminocrotonate”

Your email address will not be published. Required fields are marked *